Robert (Robin) joined Morgenthaler in 1983, bringing with him ten years of general management experience in venture-backed and emerging growth companies. Robin was General Manager of the Electronics division of Harshaw Corporation, until its sale to Kaiser in 1983. He served as Director of Marketing & Sales at Acurex Corporation from 1977 until 1980. Between 1973 and 1977, Robin was Vice President of Marketing & Sales at SHM Nuclear, which was acquired by EMI Medical.

Robin has been responsible for Morgenthaler's investment in numerous health care and information technology companies that have completed public offerings or successful mergers. He is a Director of Ardian, Cierra Medical, Ensure Medical, The Foundry, IPC-The Hospitalist Company, Satiety, Third Millennium Health Care Systems, Xtent and Wave7 Optics. In addition, he has served as a Director or was actively involved with Arbor Health Care (acquired by ExtendiCare), Athena Neurosciences (acquired by Elan), CardioThoracic Systems (acquired by Guidant), Executone, Integrated Vascular Systems (acquired by Abbott Labs), The Liposome Company (acquired by Elan), LuMend, Managed Health Network (acquired by Foundation Health), Medaphis Corporation, National Medical Diagnostics (acquired by GE Medical), Perclose (acquired by Abbott Labs), Sequana Therapeutics (acquired by Arris Pharmaceuticals), Surgical Health (acquired by HealthSouth), Thermage, Verifone (acquired by Hewlett Packard), and Vical.

Robin is a past Director of the Western Association of Venture Capitalists and the Stanford Business School Trust. From 1966 to 1971, he served as a line officer on nuclear fast attack and ballistic missile submarines. Robin received a BS in Engineering from the US Naval Academy in 1966, and an MBA from the Stanford Graduate School of Business in 1973.

Related Links: www.morgenthaler.com/ventures/   

Last Updated: Wed, Apr 19, 2006